DarioHealth Corp. Stock Analysis & AI Score
DarioHealth Corp. (DRIO) has an ST Score of 53.9 (B-), driven by its Growth (A) and held back by its Financial Strength (D). Analysts rate it Buy with a $12.50 price target (+84.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
DarioHealth Corp. (DRIO) has an ST Score of 53.9 (B-), driven by its Growth (A) and held back by its Financial Strength (D). Analysts rate it Buy with a $12.50 price target (+84.6% upside).
- Strongest
- GrowthA
- Weakest
- Financial StrengthD
All factor grades
- GrowthA
- ForecastA-
- MomentumB
- ProfitabilityB-
- ValuationC
- Financial StrengthD
- Piotroski3/9
Contact
DRIO stock: frequently asked questions
What is DRIO's ST Score?
DarioHealth Corp. (DRIO) has an ST Score of 53.9 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is DRIO a buy, hold, or sell?
Analysts rate DRIO a Buy, with a price target of $12.50 (+84.6% vs the current price). Our ST Score grades it B- (53.9/100). The ST Score is a data-driven signal, not a recommendation.
What are DRIO's factor grades?
Valuation C, Profitability B-, Financial Strength D, Momentum B, Growth A, Forecast A-.
What is DRIO's valuation grade?
DarioHealth Corp. (DRIO) earns a valuation grade of C, measured against Medical - Specialties peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is DRIO's growth grade?
DarioHealth Corp. (DRIO) earns a growth grade of A, measured against Medical - Specialties peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is DRIO's profitability grade?
DarioHealth Corp. (DRIO) earns a profitability grade of B-, measured against Medical - Specialties peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is DRIO's financial strength grade?
DarioHealth Corp. (DRIO) earns a financial strength grade of D, measured against Medical - Specialties peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for DRIO?
The average analyst price target for DarioHealth Corp. (DRIO) is $12.50 from 9 analysts, which is +84.6% versus the recent price of $6.77.
What is DRIO's Piotroski score?
DarioHealth Corp. (DRIO) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.